Qin Liu

Prof. Dr. Qin Liu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
XWXiaowen Wang
Xiaowen Wang
HZHongming Zhu
Hongming Zhu
YJYizhi Jiang
Yizhi Jiang
YLYulong Li
Yulong Li
CTChen Tang
Chen Tang
QLQin Liu
Qin Liu
Although drug combinations in cancer treatment appear to be a promising therapeutic strategy with respect to monotherapy, it is arduous to discover new synergistic drug combinations due to the combinatorial explosion. Deep learning technology holds immense promise for better prediction of in vitro synergistic drug combinations for certain cell lines. In methods applying such technology, omics data are widely adopted to construct cell line features. However, biological network data are rarely considered yet, which is worthy of in-depth study. In this study, we propose a novel deep learning method, termed PRODeepSyn, for predicting anticancer synergistic drug combinations. By leveraging the Graph Convolutional Network, PRODeepSyn integrates the protein–protein interaction (PPI) network with omics data to construct low-dimensional dense embeddings for cell lines. PRODeepSyn then builds a deep neural network with the Batch Normalization mechanism to predict synergy scores using the cell line embeddings and drug features. PRODeepSyn achieves the lowest root mean square error of 15.08 and the highest Pearson correlation coefficient of 0.75, outperforming two deep learning methods and four machine learning methods. On the classification task, PRODeepSyn achieves an area under the receiver operator characteristics curve of 0.90, an area under the precision–recall curve of 0.63 and a Cohen’s Kappa of 0.53. In the ablation study, we find that using the multi-omics data and the integrated PPI network’s information both can improve the prediction results. Additionally, the case study demonstrates the consistency between PRODeepSyn and previous studies.

22 June 2023 in Computers in Biology and Medicine
Verified
Journal Article
Open access
KYKainan Yao
Kainan Yao
XWXiaowen Wang
Xiaowen Wang
WLWannian Li
Wannian Li
HZHongming Zhu
Hongming Zhu
YJYizhi Jiang
Yizhi Jiang
QLQin Liu
Qin Liu
Identification of drug-target interactions (DTIs) is an important step in drug discovery and drug repositioning. In recent years, graph-based methods have attracted great attention and show advantages on predicting potential DTIs. However, these methods face the problem that the known DTIs are very limited and expensive to obtain, which decreases the generalization ability of the methods. Self-supervised contrastive learning is independent of labeled DTIs, which can mitigate the impact of the problem. Therefore, we propose a framework SHGCL-DTI for predicting DTIs, which supplements the classical semi-supervised DTI prediction task with an auxiliary graph contrastive learning module. Specifically, we generate representations for the nodes through the neighbor view and meta-path view, and define positive and negative pairs to maximize the similarity between positive pairs from different views. Subsequently, SHGCL-DTI reconstructs the original heterogeneous network to predict the potential DTIs. The experiments on the public dataset show that SHGCL-DTI has significant improvement in different scenarios, compared with existing state-of-the-art methods. We also demonstrate that the contrastive learning module improves the prediction performance and generalization ability of SHGCL-DTI through ablation study. In addition, we have found several novel predicted DTIs supported by the biological literature. The data and source code are available at: https://github.com/TOJSSE-iData/SHGCL-DTI.

1 June 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
XWXiaowen Wang
Xiaowen Wang
HZHongming Zhu
Hongming Zhu
DCDanyi Chen
Danyi Chen
YYYongsheng Yu
Yongsheng Yu
QLQin Liu
Qin Liu
Motivation: Drug combination therapy shows significant advantages over monotherapy in cancer treatment. Since the combinational space is difficult to be traversed experimentally, identifying novel synergistic drug combinations based on computational methods has become a powerful tool for pre-screening. Among them, methods based on deep learning have far outperformed other methods. However, most deep learning-based methods are unstable and will give inconsistent predictions even by simply changing the input order of drugs. In addition, the insufficient experimental data of drug combination screening limits the generalization ability of existing models. These problems prevent the deep learning-based models from being in service. Results: In this article, we propose CGMS to address the above problems. CGMS models a drug combination and a cell line as a heterogeneous complete graph, and generates the whole-graph embedding to characterize their interaction by leveraging the heterogeneous graph attention network. Based on the whole-graph embedding, CGMS can make a stable, order-independent prediction. To enhance the generalization ability of CGMS, we apply the multi-task learning technique to train the model on drug synergy prediction task and drug sensitivity prediction task simultaneously. We compare CGMS’s generalization ability with six state-of-the-art methods on a public dataset, and CGMS significantly outperforms other methods in the leave-drug combination-out scenario, as well as in the leave-cell line-out and leave-drug-out scenarios. We further present the benefit of eliminating the order dependency and the discrimination power of whole-graph embeddings, interpret the rationality of the attention mechanism, and verify the contribution of multi-task learning. Availability and implementation: The code of CGMS is available via https://github.com/TOJSSE-iData/CGMS.

18 May 2021 in Remote Sensing
Verified
Journal Article
Open access
PDF file
QLQin Liu
Qin Liu
LHLetong Han
Letong Han
RTRui Tan
Rui Tan
HFHongfei Fan
Hongfei Fan
WLWeiqi Li
Weiqi Li
Sicong LiuSicong Liu
Sicong Liu
Pansharpening aims at fusing the rich spectral information of multispectral (MS) images and the spatial details of panchromatic (PAN) images to generate a fused image with both high resolutions. In general, the existing pansharpening methods suffer from the problems of spectral distortion and lack of spatial detail information, which might prevent the accuracy computation for ground object identification. To alleviate these problems, we propose a Hybrid Attention mechanism-based Residual Neural Network (HARNN). In the proposed network, we develop an encoder attention module in the feature extraction part to better utilize the spectral and spatial features of MS and PAN images. Furthermore, the fusion attention module is designed to alleviate spectral distortion and improve contour details of the fused image. A series of ablation and contrast experiments are conducted on GF-1 and GF-2 datasets. The fusion results with less distorted pixels and more spatial details demonstrate that HARNN can implement the pansharpening task effectively, which outperforms the state-of-the-art algorithms.

27 November 2023 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
DCDanyi Chen
Danyi Chen
XWXiaowen Wang
Xiaowen Wang
HZHongming Zhu
Hongming Zhu
YJYizhi Jiang
Yizhi Jiang
YLYulong Li
Yulong Li
QLQin Liu
Qin Liu
Background: The discovery of anticancer drug combinations is a crucial work of anticancer treatment. In recent years, pre-screening drug combinations with synergistic effects in a large-scale search space adopting computational methods, especially deep learning methods, is increasingly popular with researchers. Although achievements have been made to predict anticancer synergistic drug combinations based on deep learning, the application of multi-task learning in this field is relatively rare. The successful practice of multi-task learning in various fields shows that it can effectively learn multiple tasks jointly and improve the performance of all the tasks. Methods: In this paper, we propose MTLSynergy which is based on multi-task learning and deep neural networks to predict synergistic anticancer drug combinations. It simultaneously learns two crucial prediction tasks in anticancer treatment, which are synergy prediction of drug combinations and sensitivity prediction of monotherapy. And MTLSynergy integrates the classification and regression of prediction tasks into the same model. Moreover, autoencoders are employed to reduce the dimensions of input features. Results: Compared with the previous methods listed in this paper, MTLSynergy achieves the lowest mean square error of 216.47 and the highest Pearson correlation coefficient of 0.76 on the drug synergy prediction task. On the corresponding classification task, the area under the receiver operator characteristics curve and the area under the precision–recall curve are 0.90 and 0.62, respectively, which are equivalent to the comparison methods. Through the ablation study, we verify that multi-task learning and autoencoder both have a positive effect on prediction performance. In addition, the prediction results of MTLSynergy in many cases are also consistent with previous studies. Conclusion: Our study suggests that multi-task learning is significantly beneficial for both drug synergy prediction and monotherapy sensitivity prediction when combining these two tasks into one model. The ability of MTLSynergy to discover new anticancer synergistic drug combinations noteworthily outperforms other state-of-the-art methods. MTLSynergy promises to be a powerful tool to pre-screen anticancer synergistic drug combinations.

4 February 2025 in IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing
Verified
Journal Article
Open access
HZHongming Zhu
Hongming Zhu
ZWZeju Wang
Zeju Wang
LHLetong Han
Letong Han
MXManxin Xu
Manxin Xu
WLWeiqi Li
Weiqi Li
BDBowen Du
Bowen Du
Optical remote sensing is heavily affected by clouds, and thus cloud removal is a critical task for obtaining accurate and reliable results. Traditional methods for remote sensing data reconstruction include spectral-based, spatial-based, timebased, and hybrid-based methods. However, these methods have inherent limitations in handling cloud removal due to the imaging mechanism of optical images. Synthetic Aperture Radar (SAR) images have been used in remote sensing image de-clouding in recent years due to their unique imaging mechanism. However, the domain gap between SAR images and multi-spectral images, the non-uniformity of cloud distribution, and the lack of mining self-similarity and correlation between different spectra of multispectral images pose challenges for SAR-based cloud removal. In this study, we propose a SAR-based cross-attention network for multi-spectral image de-clouding reconstruction. The crossattention mechanism helps regions with heavy cloud cover to refer more to the features of SAR images during reconstruction while avoiding interference from the noise interference of SAR images. Experimental results show that the proposed method outperforms state-of-the-art methods in terms of reconstruction accuracy and visual quality, demonstrating its effectiveness and potential for cloud removal in remote sensing.